Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 INmune BioGenocea BiosciencesMicrobot MedicalVaxartBIONDVAX PHARMA/S
SymbolNASDAQ:INMBNASDAQ:GNCANASDAQ:MBOTNASDAQ:VXRTNASDAQ:BVXV
Price Information
Current Price$3.35$1.82$5.64$1.68$7.40
52 Week RangeBuyBuyBuyBuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$11.33$16.33$26.00$4.50N/A
% Upside from Price Target238.31% upside797.44% upside360.99% upside167.86% upsideN/A
Trade Information
Market Cap$35.47 million$50.31 million$33.60 million$120.25 million$47.06 million
Beta1.542.114.75-0.541.33
Average Volume30,644267,845556,95010,536,91441,611
Sales & Book Value
Annual RevenueN/AN/AN/A$9.86 millionN/A
Price / SalesN/AN/AN/A12.05N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.19 per share$0.89 per share$0.40 per share$0.27 per share($1.27) per share
Price / BookN/AN/AN/A6.22N/A
Profitability
Net Income$-7,680,000.00$-38,950,000.00$-7,240,000.00$-18,650,000.00$-23,410,000.00
EPS($0.75)($2.09)($2.41)($0.86)($3.60)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A∞∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-189.06%N/A
Return on Equity (ROE)-31.33%-150.72%-120.41%-123.73%N/A
Return on Assets (ROA)-30.40%-67.80%-68.71%-48.65%-109.31%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%0.77%0.02%0.11%N/A
Current Ratio11.09%6.62%2.29%1.92%25.14%
Quick Ratio11.09%6.62%2.29%1.92%25.14%
Ownership Information
Institutional Ownership Percentage2.63%53.58%10.25%56.21%7.30%
Insider Ownership Percentage67.67%2.33%14.47%7.30%6.03%
Miscellaneous
Employees36193414
Shares Outstanding10.75 million27.64 million6.29 million70.73 million6.54 million
Next Earnings Date6/10/2020 (Estimated)5/5/2020 (Estimated)5/20/2020 (Estimated)5/14/2020 (Estimated)6/4/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel